POSC.OB - Sector: Healthcare --- Industry: Medical Appliances & Equipment

[setravis]

Looks like it is time to Rock with this stock.

Recent CandleStick Analysis
Very Bullish
Feb-22-2006 Bullish Engulfing  
Feb-17-2006 Bullish Engulfing
Today a Long White Candlestick was formed. This shows that the prices advanced significantly from open to close during the day under strong buying pressure.

Support @ 0.15...0.14...0.13
Resistance @ 0.18

Technicals
MACD is Bullish
Close Above the 13-day EMA
Percentage Gainer

Last Price Quote is:
22.71%above 13-day EMA
57.39%above 50-day EMA

[setravis]

Profile Get Profile for:
 

Positron Corp.
1304 Langham Creek Drive
Suite 300
Houston, TX 77084
Phone: 281-492-7100
Fax: 281-492-2961
Web Site: http://www.positron.com

DETAILS   
Index Membership: N/A
Sector: Healthcare
Industry: Medical Appliances & Equipment
Full Time Employees: 16


BUSINESS SUMMARY   
Positron Corporation engages in the design, manufacture, marketing, and servicing of advanced medical imaging devices utilizing positron emission tomography (PET) technology. The company offers its products under the name 'POSICAM' that apply PET technology, which is an advanced imaging technique that permits the measurement of the biological processes of organs and tissues, as well as produces anatomical and structural images. Its POSICAM systems enable physicians to diagnose and treat patients in the areas of cardiology, neurology, and oncology. POSICAM systems are used to assess the presence and extent of coronary artery disease, such as the effect of arterial blockages and heart damage due to heart attacks; diagnoses of certain brain disorders, such as epileptic seizures, dementia, stroke, Alzheimer's disease, Pick's disease, and Parkinson's disease; and are used in the diagnosis and evaluation of melanoma and tumors of the bone and various organs and tissues, such as the brain, lungs, liver, colon, breasts, and lymphatic system. The company also offers two versions, POSICAM HZ and POSICAM HZL. POSICAM's are primarily used by oncologists and neurologists to detect small tumors and scan large organs, such as the liver. Positron was established in 1983 and is headquartered in Houston, Texas.

[setravis]

Hello......


Technicals
Record Price High
Close Above the 13-day EMA

Last Price Quote is:
37.88%above 13-day EMA
76.84%above 50-day EMA

[setravis]

How was your day? Yours truly had an unforgettable session 

Volume: 1,696,050
Avg Volume (3m): 269,847

Technicals
Record Price High
Percentage Gainer

Last Price Quote is:
46.47%above 13-day EMA
90.73%above 50-day EMA

[higherstocks]

Good find SetTravis do you have a position?  What is your target?  I might ride with you on this one. 

[gmarc66]

Nice Setravis!!

I have this on my watchlist since u brought it to my attention..but, i got so caught up with all the sub-pennies moving, i didnt get a chance to keep my eye on this..and many others.

Very nice though. So, do u think it still has more to go?

glta..nice job as usual

julia

[setravis]

Thanks Julia....higherstocks.
I did take up a position in this one.I don't know what to say about a target.
But some points of interest could be 0.30...0.40...0.50
Go and take a look at the longer term charts on this say, 4, 5 and 10 year charts.If you can post those longer term charts here do so, I can't.
This little baby could go much higher.

[higherstocks]

Hey Settravis and Julia here is a 4 year chart on POSC

[doyerdiligence]

damnnn weee haa i guess that is what i get for showing up late to a party when powa was back in town....
market is just so crazy tho BUT GREEAT action here powa~!!!!

[doyerdiligence]

# of trades (50days) : posc : 105 62 49 71 58 11 19 19 10 15 18 34 129 33 4 18 15 6 11 17 37 38 101 25 16 5 16 10 10 12 6 6 2 26 26 57 10 4 5 2 16 16 10 17 17 11 11 10 3 8

POSC.OB Average Volume:
3days: 867165 +93.1%
10d: 449180 +1.5%
30d: 442558 +47.6%
90d: 232091 +34.4%
180d: 152361

[Livana]

I forgot I put a buy order for this little guy a few days ago for 0.19... and well, it got fill this morning.
I remember last nigh looking more into it to try to decide whether I was going to keep the order open or not, and as usual, I got side-tracked looking at other post and stocks, so the order stayed 

Well, let's go now... 

[gmarc66]

Setravis you Rock! And so did POSC today Sadly, i didnt get in...darn it..i almost did near eod when i saw the vol kick in and pps on the rise.

Great pick yet again!

I'm still baffled as to how you hone in and source out these slow, steady but sure baggers

Setravis please provide your TA for this guy and any projections you have Even though all u have to really say  is 'Yeeeeeeehaaaaaaa!'

thanks!

julia

[Livana]

Anyone can tell me what the forecast on POSC is?
I got in 2 weeks ago on when it was bouncing back up, but it's been falling ever since... any sign of that trend reversing?

[Livana]

POSC is down 21% today. Hitting a LOD of 0.12.  It bounced a little since then and is curently at 0.13.
No news have been out, so I'm a little lost as to the loss.

[setravis]

Press Release Source: Positron Corporation


Positron Acquires IS2 Medical Systems, a Nuclear Imaging Device Manufacturer
Monday June 19, 8:33 am ET


HOUSTON--(BUSINESS WIRE)--June 19, 2006--Positron Corporation (OTCBB:POSC - News; the "Company"), a developer and manufacturer of positron emission tomography (PET) medical devices and a leader in cardiac PET, announced today that the Company has completed the acquisition of IS2 Medical Systems, Inc. ("IS2") a leading developer and manufacturer of nuclear imaging devices based in Ottawa, Ontario, Canada.


IS2's signature product is its PulseCDC(TM) compact digital cardiac camera which provides the best quality images at the lowest price in the industry. The scientific team responsible for the design and continued innovation of the company's world-class cameras comprise more than 125 years of expertise in nuclear medicine, physics, mathematics and engineering.

Through a majority-owned subsidiary, Imaging PET Technologies, Inc. (IPT), formed in joint venture with Quantum Molecular Pharmaceuticals Inc., a Canadian radiopharmaceutical company, the Company acquired all of IS2's operating assets in a transaction negotiated with IS2's secured debtholders.

The Company's investment in IS2 is the first transaction from proceeds of its recent financing that is dedicated for the expansion of its cardiac camera and clinic businesses. The acquisition adds immediate value to Positron as a technological leader in nuclear medicine devices. Positron will benefit from IS2's top tier technical resources, marketing expertise and credibility in the nuclear medicine marketplace.

Joseph Oliverio, President of Positron Corporation stated, "In addition to IS2's well-established market traction and quality product, the excellence of IS2 comes from the depth of the team which has an optimal mix of clinical, technical and business expertise. Positron and IS2 will integrate select resources and expertise that both companies possess that will mutually benefit in increased sales, greater software development capabilities, more efficient and effective marketing and R&D budget and to the ability to meet the production timelines that both companies sales cycle demands. We are ideally positioned to execute our business plan and take a leadership role in nuclear medicine."

"This transaction will be a catalyst for continued sales growth while also allowing synergies from sister companies to contribute toward the develop of new technologies in PET, cardiac and general purpose imaging as well as the development of specialized technologies including breast, brain, and prostate imaging," commented Steve Horvath, President of IS2.

About Positron:

Positron Corporation designs, manufactures, markets and supports advanced medical imaging devices utilizing positron emission tomography (PET) technology under the trade name POSICAM(TM) systems. POSICAM(TM) systems incorporate patented and proprietary software and technology for the diagnosis and treatment of patients in the areas of cardiology, oncology and neurology. Positron Corporation offers unique combination of low cost technology and disease specific software solutions differentiating themselves from all other medical device manufacturers. POSICAM(TM) systems are in use at leading medical facilities, including the Weatherhead PET center at the University of Texas Health Science Center in Houston, Texas; The Heart Center of Niagara in Niagara Falls, New York; Beth Israel Medical Center, New York; Emory Crawford Long Hospital Carlyle Fraser Heart Center in Atlanta, Georgia; and Nishidai Clinic (Diagnostic Imaging Center) in Tokyo, Japan. Additional information may be found at www.positron.com.

About IS2 Medical Systems, Inc.:

IS2 Medical develops, builds and services gamma cameras that offer clinical users some of the best performance specifications in the industry, at reasonable and competitive prices. Revenue growth has been double digit for multiple years, largely as a result of the PULSECDC, a small-footprint cardiac camera ideal for clinics. Over 150 cameras have been sold in the U.S., Canada, Europe, Asia and other world markets. For more information, visit: www.is2medical.com

Forward Looking Statements:

Statements in this document contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended. These statements are based on many assumptions and estimates and are not guarantees of future performance and may involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Positron Corporation to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. The words "expect," "anticipate," "intend," "plan," "believe," "seek," "estimate," and similar expressions are intended to identify such forward-looking statements. Our actual results may differ materially from the results anticipated in these forward-looking statements due to a variety of factors, including, without limitation those set forth as "Risk Factors" in our filings with the Securities and Exchange Commission.

For further information please contact Positron Corporation at (281) 492-7100.

Contact:
Positron Corporation
Joseph Oliverio, 281-492-7100

--------------------------------------------------------------------------------
Source: Positron Corporation


Headline News Link :
http://finance.yahoo.com/q/h?s=POSC.OB